CINECA IRIS Institutional Research Information System

TUCCORI, MARCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.183
AS - Asia 3.258
EU - Europa 2.424
SA - Sud America 493
AF - Africa 275
Continente sconosciuto - Info sul continente non disponibili 190
OC - Oceania 36
Totale 13.859
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.997
SG - Singapore 1.064
CN - Cina 750
IT - Italia 702
HK - Hong Kong 417
SE - Svezia 409
BR - Brasile 368
VN - Vietnam 314
GB - Regno Unito 276
DE - Germania 265
IN - India 180
BG - Bulgaria 157
FR - Francia 157
TR - Turchia 116
FI - Finlandia 109
JP - Giappone 108
CI - Costa d'Avorio 105
CA - Canada 95
RU - Federazione Russa 76
NL - Olanda 49
SN - Senegal 47
MX - Messico 46
IQ - Iraq 43
NG - Nigeria 42
UA - Ucraina 40
ID - Indonesia 38
BD - Bangladesh 37
AU - Australia 35
PL - Polonia 30
AR - Argentina 28
KR - Corea 26
ES - Italia 25
BE - Belgio 22
CO - Colombia 21
AT - Austria 20
PK - Pakistan 20
UZ - Uzbekistan 20
SA - Arabia Saudita 18
VE - Venezuela 18
CL - Cile 17
EC - Ecuador 17
ZA - Sudafrica 17
MY - Malesia 14
PT - Portogallo 13
EG - Egitto 12
IR - Iran 12
JO - Giordania 12
MA - Marocco 12
CH - Svizzera 10
CR - Costa Rica 10
PH - Filippine 10
LT - Lituania 9
PE - Perù 9
DZ - Algeria 8
KE - Kenya 8
PY - Paraguay 8
IE - Irlanda 7
IL - Israele 7
JM - Giamaica 7
AE - Emirati Arabi Uniti 6
CZ - Repubblica Ceca 6
RS - Serbia 6
TN - Tunisia 6
TT - Trinidad e Tobago 6
AZ - Azerbaigian 5
RO - Romania 5
TW - Taiwan 5
XK - ???statistics.table.value.countryCode.XK??? 5
AL - Albania 4
BB - Barbados 4
DO - Repubblica Dominicana 4
GR - Grecia 4
KZ - Kazakistan 4
LV - Lettonia 4
NP - Nepal 4
PS - Palestinian Territory 4
DK - Danimarca 3
ET - Etiopia 3
EU - Europa 3
HR - Croazia 3
KG - Kirghizistan 3
NI - Nicaragua 3
TH - Thailandia 3
UY - Uruguay 3
AO - Angola 2
BJ - Benin 2
BO - Bolivia 2
CG - Congo 2
EE - Estonia 2
GE - Georgia 2
GH - Ghana 2
GT - Guatemala 2
HN - Honduras 2
LB - Libano 2
LY - Libia 2
MK - Macedonia 2
PA - Panama 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
Totale 13.647
Salva come PNG Salva come JPEG
Città #
Ashburn 763
Singapore 626
San Jose 419
Santa Clara 416
Hong Kong 409
Chandler 308
Dallas 294
Ann Arbor 256
Woodbridge 240
Shanghai 235
Fairfield 224
Houston 173
Sofia 155
New York 143
Beijing 131
Los Angeles 126
Boardman 122
Abidjan 105
Florence 104
Wilmington 96
Milan 93
Serra 92
London 91
Ho Chi Minh City 90
Seattle 85
Tokyo 85
Munich 80
Princeton 75
Cambridge 74
Hanoi 70
Lauterbourg 69
Lawrence 64
Medford 57
Istanbul 55
Council Bluffs 49
Dakar 47
Atlanta 46
Ottawa 45
Helsinki 44
Pisa 41
Lagos 40
Frankfurt am Main 39
Buffalo 38
Izmir 37
Jacksonville 36
Rome 34
Dong Ket 32
Redwood City 32
Turku 32
Mumbai 31
Bremen 28
Chicago 28
Des Moines 28
Washington 26
Kent 25
San Francisco 25
São Paulo 25
Lancaster 23
Nanjing 22
Phoenix 22
Hyderabad 21
Warsaw 21
Brussels 20
Denver 20
Rio de Janeiro 20
Brooklyn 19
Massa 19
Redondo Beach 19
Baghdad 18
Tashkent 18
Hefei 17
San Diego 17
Fuzhou 16
Jakarta 16
Orem 16
Chennai 15
Düsseldorf 15
Mexico City 15
Da Nang 14
Ogden 13
Santiago 13
Dearborn 12
Haiphong 12
Johannesburg 12
Montreal 12
Amman 11
Manchester 11
Norwalk 11
Seoul 11
Toronto 11
Belo Horizonte 10
Curitiba 10
Memphis 10
Mountain View 10
Nanchang 10
Nuremberg 10
Vancouver 10
Amsterdam 9
Bengaluru 9
Livorno 9
Totale 7.862
Salva come PNG Salva come JPEG
Nome #
Raynaud’s Phenomenon Associated with Calcitonin Gene-Related Peptide (CGRP) Antagonists: a Disproportionality Analysis on VigiBase 841
Erratum to: Deliberate Self-Poisoning: Real-Time Characterization of Suicidal Habits and Toxidromes in the Food and Drug Administration Adverse Event Reporting System (Drug Safety, (2023), 46, 3, (283-295), 10.1007/s40264-022-01269-x) 292
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis 265
Disproportionality Analysis of ‘‘Early-Onset’’ Tardive Dyskinesia Stratified by Time to Onset Using FAERS Database. 264
Acute portal vein thrombosis precipitated by indomethacin in a HCV-positive elderly patient 263
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 251
Oral Presentation: Signal of Hypertension Associated with COVID-19 Vaccination: VigiBase (R) Data and Evidence from Real World 230
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 227
Supporting the Spontaneous Reporting by Health Care Professionals of the University Hospital of Pisa, Italy: a Pilot Project from the Unit of Adverse Drug Reactions Monitoring 220
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 213
Gabapentin-induced severe myopathy: a case report 204
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 201
Tixagevimab + cilgavimab against SARS-CoV-2: the preclinical and clinical development and real-world evidence 200
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) 199
Lessons learnt from the preclinical discovery and development of ensitrelvir as a COVID-19 therapeutic option 197
Fatal hepatitis after long-term pulse itraconazole treatment for onychomycosis: a case report with review of literature 187
Role of A2a adenosine in the regulation of colonic motility in normal human colon 186
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 186
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study 179
Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope 176
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy 176
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy 175
Adherence with regulatory resolutions on prevention of NSAIDS-related gastrointestinal injury in Italy 173
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 172
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 168
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) 168
Fatal Fat Overload Syndrome Following Intravenous Lipid Emulsion Administration as Antidote in Suspected Anesthetic Intoxication: A Fatal Medication Error. 165
Validation test for algorithms to identify rheumatoid arthritis patients in the Tuscan healthcare administrative databases 161
Utilisation patterns and clinical impact of the introduction of infliximab-biosimilar in Tuscany, Italy: real world evidence following the recommendation of switching for non-medical reasons 160
Antibiotic Drugs and Unresolved Sensory Side Effects: Analysis of Eudravigilance Database of Suspected Adverse Drug Reaction Reports 159
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 157
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 156
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 156
Functional Neuroplasticity in Acute Diverticulitis: Differential Regulation of Colonic Excitatory Nerve Pathways By Cyclooxygenase Isoforms 155
Olfactory and gustatory impairments in COVID-19 patients: Role in early diagnosis and interferences by concomitant drugs 152
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline 149
Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials 145
Progressive multifocal leukoencephalopathy and anti-CD20 monoclonal antibodies: What do we know after 20 years of rituximab 145
COVID-19 Vaccines and Thromboembolic Events with Thrombocytopenia: Data from Italian Pharmacovigilance Public Database 144
Analysis of fatal adverse drug events recorded in several Italian emergency departments (the MEREAFaPS study) 142
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database 138
Potential and Actual Drug-Drug Interactions in Elderly Patients Admitted to an Emergency Department: Data from the ANCESTRAL-ED Study 135
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact 135
Listening Social Media for Pharmacovigilance Objectives: Which Usefulness? 135
Acute severe myopathy following single intravenous infusion of omeprazole 134
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy 134
Anticoagulant Therapy and Risk of Bleeding in Patients with Atrial Fibrillation of Four Italian Regions: The TYRION Study 134
Utilization patterns and healthcare accesses of JAKi used in rheumatoid arthritis patients in Tuscany: The LEONARDO study 133
Bleeding Related to Oral Anticoagulant Drugs as Cause of Emergency Department Admission: Analysis of Data from the Tuscan MEREAFaPS Network 132
Role of the A(2B) receptor-adenosine deaminase complex in colonic dysmotility associated with bowel inflammation in rat 131
An overview of the preclinical discovery and development of bamlanivimab for the treatment of novel coronavirus infection (COVID-19): reasons for limited clinical use and lessons for the future 129
Adverse drug reactions in oncoLogy: intEnsive monitoring program on biotechnological anD taRget therapies in Oncologic patientS-ALEXANDROS observational study 128
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy 128
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES 128
IntenSive Monitoring Program of TeratOgen and Non-Teratogen Risk of Drugs During Pregnancy: the STORK Project 127
Exploring the relationship between utilization patterns of biologic disease-modifying anti-rheumatic drugs and disease activity in rheumatoid arthritis patients 123
A clinician network for sharing patients experiences in pharmacovigilance: the PHARMACOWIKILANCE project 123
Evaluation of drug-utilization and healthcare facilities use in patients with ulcerative colitis and treated with biologic therapy using data of an Italian healthcare administrative database: Results from michelangelo study 122
Estimation of Theoretical Cost Preventability Achievable with an Effective Pharmacovigilance Activity in a Pharmacovigilance Regional Centre in Italy 120
Characterization of the Risk of Bleeding with Novel Oral Anticoagulants and Warfarin: A Pilot Case-Control Study 119
Checkpoint inhibitors and progressive multifocal leukoencephalopathy: friends of foes? 118
Statin-associated psychiatric adverse events: a case/non case evaluation of an Italian database of spontaneous adverse drug reaction reporting 118
SSRIs and birth defects: Can a new statistical approach resolve old controversies? 117
Analysis of the Drug Related Emergency Department Admissions in Tuscany: The FARO Project 114
A regulatory overview of biosimilars across selected countries 113
Anti-tumor Necrosis Factor Drugs and Risk of Lymphoma in Patients with Inflammatory Bowel Disease 113
Exploring pharmacological approaches for managing cytokine storm associated with pneumonia and acute respiratory distress syndrome in COVID-19 patients 113
Anticoagulant Therapy in Patients with Atrial Fibrillation and Risk of Bleeding: Interim Analysis: Tyrion Study 112
Risk of hospitalisation associated with benzodiazepines and z-drugs in Italy: a nationwide multicentre study in emergency departments 112
Discontinuation rate to biologic and targeted synthetic DMARDs in rheumatoid arthritis patients: Systematic review and meta-analysis 111
Update of Certolizumab Pegol Safety Profile: A Systematic Review and Meta-Analysis 111
The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance 110
A Model-Based Analysis on Direct Costs of Adverse Drug Events and Related Cost-Savings Achievable by their Prevention in Tuscany, Italy 110
Large-Scale Postmarketing Surveillance of Biological Drugs for Immune-Mediated Inflammatory Diseases Through an Italian Distributed Multi-Database Healthcare Network: The VALORE Project 109
Use of antiseizure medications and safety of branded versus generic formulations: A comparative study on Tuscan administrative databases 106
Italian Emergency Department Visits and Hospitalizations for Outpatients’ Adverse Drug Events: 12-Year Active Pharmacovigilance Surveillance (The MEREAFaPS Study) 101
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy 101
Muscular adverse drug reactions associated with proton pump inhibitors: a disproportionality analysis using the Italian National Network of Pharmacovigilance database 100
Use of Biological Drugs for Psoriasis: A Drug-Utilization Study Using Tuscan Administrative Databanks 98
Haemorrhagic gastritis and bleeding following rofecoxib administration 97
Fat overload syndrome following intravenous lipid emulsion administration as antidote in suspected anesthetic intoxication: insights from a clinical and forensic case experience 95
Potential missed diagnoses of Crohn's disease in tertiary care: impact on drug utilization and healthcare facilities use 95
Severe Cardiac Events Following Treatment with Trastuzumab in Women with Breast Cancer: A Meta-Analysis of Clinical Trials and Cohort Studies 93
Communicating Drug Safety 91
Assessment of Healthcare Facilities Associated with JAKi Drugs Used in Rheumatoid Arthritis Patients in Tuscany, Italy: The LEONARDO 87
Biosimilars approvals by thirteen regulatory authorities: A cross-national comparison 82
Oral Presentation: Accesses to Emergency Department and Hospitalizations in New Users of Biologic Therapies for Ulcerative Colitis in Tuscany: The MICHELANGELO Study 81
Signals of Possibly Persistent Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Disproportionality Analysis Using the EudraVigilance Database 71
A Cross-National Comparison of Biosimilars Pricing in Argentina, Australia, Brazil, and Italy 65
Unresolved Gustatory, Olfactory and Auditory Adverse Drug Reactions to Antibiotic Drugs: A Signal Detection Analysis on Publicly Accessible Eudravigilance Data 59
Risk of Hospitalization Associated with Cardiovascular Medications in the Elderly Italian Population: A Nationwide Multicenter Study in Emergency Departments 57
Authors’ response: Inhibiting IL-6 in COVID-19: we are not sure that sgp130(fc) can affect only the trans-signaling receptor pathway of IL-6 52
Totale 13.859
Salva come PNG Salva come JPEG
Categoria #
all - tutte 44.213
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 44.213
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022916 0 42 86 88 148 132 31 45 53 22 63 206
2022/20231.275 170 214 83 98 114 123 31 72 259 2 103 6
2023/20241.011 64 61 81 35 122 166 98 52 42 50 116 124
2024/20253.256 38 121 111 241 267 396 243 111 338 387 327 676
2025/20264.257 413 271 348 268 437 227 602 160 288 367 787 89
2026/20271.273 407 866 0 0 0 0 0 0 0 0 0 0
Totale 13.859